Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity

Sorafenib and regorafenib are tyrosine kinase inhibitors that are used in the treatment of hepatocellular carcinoma and which have similar chemical structures and toxicity profiles. We herein report a case in which regorafenib treatment could be continued for 10 months and stable disease could be ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshioka, Naoki, Kuzuya, Teiji, Ito, Takanori, Ishizu, Yoji, Honda, Takashi, Ishikawa, Tetsuya, Ishigami, Masatoshi, Fujishiro, Mitsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815910/
https://www.ncbi.nlm.nih.gov/pubmed/31243207
http://dx.doi.org/10.2169/internalmedicine.2812-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815910/
https://www.ncbi.nlm.nih.gov/pubmed/31243207
http://dx.doi.org/10.2169/internalmedicine.2812-19

Ejemplares similares